TRANSITION AND GENERAL RELEASE AGREEMENTTransition and General Release Agreement • January 26th, 2021 • Arch Therapeutics, Inc. • Surgical & medical instruments & apparatus • Massachusetts
This Transition and General Release Agreement (the “Agreement”) is entered into as of December 31, 2020 by Richard E. Davis (the “Executive”) and the Arch Therapeutics, Inc. (the “Company”) (collectively referred to as the “Parties”). As used in this Agreement, the “Company” shall include the Company, its subsidiaries and divisions, and their present and past directors, officers, employees, agents, and representatives.
